|

SHR-1701；Capecitabine；Oxaliplatin Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Suzhou Suncadia Biopharmaceuticals Co., Ltd.1

Indications

  • Locally Advanced Rectal Cancer1
  • Cancer1

Other1 trial

SHR-1701 in Combination With Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.